Pure Extracts Technologies Corp (fka PRXTF)

[barnyarddog]

December 30, 2020 PR, Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, is pleased to announce that it is commencing a study on the formulation and manufacturing of psilocybin based active treatments for oral tablets, capsules and a nasal gel that will be used as an investigational product. The study with be conducted at the Toronto Institute of Pharmaceutical Technology (“TIPT”) by Dr. Alexander MacGregor, a key scientific advisor to the Company.

... His company has a Health Canada Drug Establishment License, a Cannabis Drug License and a Dealer’s License issued under the Controlled Drugs and Substances Act (CDSA) and is thus licensed to possess psychedelic drug compounds.

https://pureextractscorp.com/news/pure-extracts-commences-study-on-psilocybin-oral-tablets-capsules-and-nasal-gel